Warning letter
Penn Pharmaceuticals Services Ltd.: warning letter of Jun 11, 2013
FDA warning letter 396210 · Center for Devices and Radiological Health
Key facts
| Reference number | 396210 |
|---|---|
| Company | Penn Pharmaceuticals Services Ltd. |
| Subject | Quality System Regulation for Medical Devices/Adulterated |
| Issue date | Jun 11, 2013 |
| Posted date | Jun 11, 2013 |
| Issuing office | Center for Devices and Radiological Health |
| Product type | Devices |
| CFR sections cited | 820 |
| Inspection city | Tredegar |
| Inspection start date | Feb 4, 2013 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: